Cargando…

The influence of acute kidney disease on the clinical outcomes of patients who received cisplatin, carboplatin, and oxaliplatin

BACKGROUND AND AIMS: Cisplatin (CDDP) is used as the first line of treatment for some tumors, but its use may be restricted due to its nephrotoxicity. Carboplatin (CARBO) and oxaliplatin (OXA) are less nephrotoxic alternatives to CDDP. This study has the objective to determine the incidence of acute...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fernandes, Alexandre Ricardo Da Silva, de Brito, Germana Alves, Baptista, Aline Lourenço, Andrade, Luis André Silvestre, Imanishe, Marina Harume, Pereira, Benedito Jorge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753493/ https://www.ncbi.nlm.nih.gov/pubmed/35036578 http://dx.doi.org/10.1002/hsr2.479

Ejemplares similares

Clinical study of complications of a peripherally inserted central catheter in cancer patients
por: Bonfim, André Luis Victor, et al.
Publicado: (2023)

Nephrotic syndrome associated with metastatic melanoma: a case report
por: Bienes, Fabiana Almeida Antonio, et al.
Publicado: (2022)

Comparison of Renal Functions Evaluated by Measured Glomerular Filtration Rate in Patients Treated With Cisplatin, Carboplatin, and Oxaliplatin
por: Choudhary, Rajnee, et al.
Publicado: (2023)

Role of the DNA Base Excision Repair Protein, APE1 in Cisplatin, Oxaliplatin, or Carboplatin Induced Sensory Neuropathy
por: Kelley, Mark R., et al.
Publicado: (2014)

Cisplatin and carboplatin pharmacokinetics in a pediatric patient with hepatoblastoma receiving peritoneal dialysis
por: Nijstad, A. Laura, et al.
Publicado: (2020)

Oxaliplatin-Based Doublets Versus Cisplatin or Carboplatin-Based Doublets in the First-Line Treatment of Advanced Nonsmall Cell Lung Cancer
por: Yu, Jing, et al.
Publicado: (2015)

Carboplatin and oxaliplatin in sequenced combination with bortezomib in ovarian tumour models
por: Al-Eisawi, Zaynab, et al.
Publicado: (2013)

The Effect of Cucurbit[7]uril on the Antitumor and Immunomodulating Properties of Oxaliplatin and Carboplatin
por: Pashkina, Ekaterina, et al.
Publicado: (2021)

Cisplatin/carboplatin cross-resistance in ovarian cancer.
por: Gore, M. E., et al.
Publicado: (1989)

Will the Interactions of Some Platinum (II)-Based Drugs with B-Vitamins Reduce Their Therapeutic Effect in Cancer Patients? Comparison of Chemotherapeutic Agents such as Cisplatin, Carboplatin and Oxaliplatin—A Review
por: Szefler, Beata, et al.
Publicado: (2023)

Interdisciplinary Healthcare Team Experience of Carboplatin and Oxaliplatin Desensitizations in a Tertiary Referral University Hospital
por: Tunakan Dalgic, Ceyda, et al.
Publicado: (2023)

Paclitaxel-etoposide-carboplatin/cisplatin versus etoposide-carboplatin/cisplatin as first-line treatment for combined small-cell lung cancer: a retrospective analysis of 62 cases
por: Li, Yue-Ya, et al.
Publicado: (2015)

Haematological toxicity of carboplatin and cisplatin combined with whole body hyperthermia in rats.
por: Ohno, S., et al.
Publicado: (1993)

Comparative evaluation of cisplatin and carboplatin sensitivity in endometrial adenocarcinoma cell lines.
por: Rantanen, V., et al.
Publicado: (1994)

Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer
por: Kim, Eric S., et al.
Publicado: (2017)

Comparative gonadotoxicity of the chemotherapy drugs cisplatin and carboplatin on prepubertal mouse gonads
por: Allen, Caroline M, et al.
Publicado: (2020)

Genotoxicity of cisplatin and carboplatin in cultured human lymphocytes: a comparative study
por: AZAB, Belal, et al.
Publicado: (2019)

Comparison of Carboplatin With Cisplatin in Small Cell Lung Cancer in US Veterans
por: Azar, Ibrahim, et al.
Publicado: (2022)

Evaluation for Synergistic Effects by Combinations of Photodynamic Therapy (PDT) with Temoporfin (mTHPC) and Pt(II) Complexes Carboplatin, Cisplatin or Oxaliplatin in a Set of Five Human Cancer Cell Lines
por: Lange, Carsten, et al.
Publicado: (2018)

Long-term platinum retention after treatment with cisplatin and oxaliplatin
por: Brouwers, Elke EM, et al.
Publicado: (2008)

Does Doxycycline work in synergy with cisplatin and oxaliplatin in colorectal cancer?
por: Sagar, Jayesh, et al.
Publicado: (2009)

Review of Cisplatin and Oxaliplatin in Current Immunogenic and Monoclonal Antibody Treatments
por: Mehmood, Rao Khalid
Publicado: (2014)

Review of Cisplatin and Oxaliplatin in Current Immunogenic and Monoclonal Antibodies Perspective
por: Mehmood, Rao Khalid, et al.
Publicado: (2014)

Response of peritoneal solid tumours after intraperitoneal chemohyperthermia treatment with cisplatin or carboplatin.
por: Los, G., et al.
Publicado: (1994)

Amrubicin: potential in combination with cisplatin or carboplatin to treat small-cell lung cancer
por: Ding, Qian, et al.
Publicado: (2013)

Correction: Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer
Publicado: (2018)

Chemoradiation with Cisplatin vs. Carboplatin for Squamous Cell Carcinoma of the Head and Neck (SCCHN)
por: Rades, Dirk, et al.
Publicado: (2023)

Cisplatin and Oxaliplatin Toxicity: Importance of Cochlear Kinetics as a Determinant for Ototoxicity
por: Hellberg, Victoria, et al.
Publicado: (2009)

Cisplatin, Oxaliplatin, and Kiteplatin Subcellular Effects Compared in a Plant Model
por: Papadia, Paride, et al.
Publicado: (2017)

Identification of New Regulators of Pancreatic Cancer Cell Sensitivity to Oxaliplatin and Cisplatin
por: Skripova, Vera, et al.
Publicado: (2022)

Culture media, DMSO and efflux affect the antibacterial activity of cisplatin and oxaliplatin
por: Gupta, A., et al.
Publicado: (2022)

Cisplatin versus carboplatin in combination with paclitaxel as neoadjuvant regimen for triple negative breast cancer
por: Huang, Liang, et al.
Publicado: (2017)

Safety and Efficacy of Weekly Paclitaxel and Cisplatin Chemotherapy for Ovarian Cancer Patients with Hypersensitivity to Carboplatin
por: Tate, Shinichi, et al.
Publicado: (2021)

Cisplatin or carboplatin for advanced non-small cell lung cancer: does it really matter?
por: Kesireddy, Meghana, et al.
Publicado: (2021)

The Use of Calcium and Magnesium to Prevent Neurotoxicity in Patients Receiving Oxaliplatin
por: Martyn, Karon, et al.
Publicado: (2015)

Hyperammonemic encephalopathy in a patient receiving fluorouracil/oxaliplatin chemotherapy
por: Ihoriya, Hiromi, et al.
Publicado: (2018)

Early nucleolar responses differentiate mechanisms of cell death induced by oxaliplatin and cisplatin
por: Sutton, Emily C., et al.
Publicado: (2021)

Reactions of cisplatin and oxaliplatin with penicillin G: implications for drug inactivation and biological activity
por: Wang, Fang-Xin, et al.
Publicado: (2022)

Hepatic changes after treatment with oxaliplatin
por: Tenório, Leila Pereira, et al.
Publicado: (2019)

Platinum-DNA adduct formation in leucocytes of children in relation to pharmacokinetics after cisplatin and carboplatin therapy.
por: Peng, B., et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_1s1vs24o1jdeavjsgb4h8o00fl